TY 2015 Form 990 Schedule J

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column(B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1ARMATO CARLCEO & PRESIDENT NOVANT HEALTH	(i) (ii)	1,306,659 ------------- 0	1,019,029 ------------- 0	518,288 ------------- 0	59,400 ------------- 0	35,263 ------------- 0	2,938,639 ------------- 0	7,500 ------------- 0
2HARGETT FREDEVP & CHIEF FINANCIAL OFFICER	(i) (ii)	811,869 ------------- 0	580,244 ------------- 0	291,358 ------------- 0	59,400 ------------- 0	33,083 ------------- 0	1,775,954 ------------- 0	7,500 ------------- 0
3MORRIS JOHNASST SEC	(i) (ii)	261,368 ------------- 0	48,750 ------------- 0	5,512 ------------- 0	48,854 ------------- 0	28,077 ------------- 0	392,561 ------------- 0	0 ------------- 0
4WALSH BETSYASST SEC	(i) (ii)	260,834 ------------- 0	60,000 ------------- 0	5,355 ------------- 0	43,788 ------------- 0	30,116 ------------- 0	400,093 ------------- 0	7,500 ------------- 0
5ALUKO AKINYELE MDSVP NH HEART & VASCULAR	(i) (ii)	464,570 ------------- 0	253,371 ------------- 0	12,494 ------------- 0	131,893 ------------- 0	20,929 ------------- 0	883,257 ------------- 0	0 ------------- 0
6BEST DIANASVP CLINICAL IMPROVEMENT	(i) (ii)	379,771 ------------- 0	225,248 ------------- 0	17,547 ------------- 0	59,400 ------------- 0	24,987 ------------- 0	706,953 ------------- 0	7,500 ------------- 0
7BRUNSTETTER PETEREVP & CHIEF LEGAL OFFICER	(i) (ii)	475,707 ------------- 0	305,850 ------------- 0	29,740 ------------- 0	157,824 ------------- 0	31,202 ------------- 0	1,000,323 ------------- 0	0 ------------- 0
8COOK DAVID MDSVP & HEALTHCARE FUTURIST	(i) (ii)	449,073 ------------- 0	235,817 ------------- 0	33,071 ------------- 0	120,563 ------------- 0	29,931 ------------- 0	868,455 ------------- 0	0 ------------- 0
9CURETON JESSEEVP & CHIEF CONSUMER OFFICER	(i) (ii)	610,977 ------------- 0	502,171 ------------- 0	28,599 ------------- 0	183,945 ------------- 0	35,606 ------------- 0	1,361,298 ------------- 0	0 ------------- 0
10DANIELS JACQUELINEEVP & CHIEF ADMIN OFFICER	(i) (ii)	605,353 ------------- 0	479,929 ------------- 0	31,105 ------------- 0	65,400 ------------- 0	17,151 ------------- 0	1,198,938 ------------- 0	7,500 ------------- 0
11GARMON-BROWN OPHELIA MDSVP COMM WELLNESS & EDUCATION	(i) (ii)	367,120 ------------- 0	288,402 ------------- 0	22,266 ------------- 0	119,207 ------------- 0	27,344 ------------- 0	824,339 ------------- 0	7,500 ------------- 0
12GARRETT DAVIDSVP CHIEF INFO OFFICER	(i) (ii)	445,653 ------------- 0	252,645 ------------- 0	25,843 ------------- 0	130,154 ------------- 0	27,567 ------------- 0	881,862 ------------- 0	7,500 ------------- 0
13JOHNSON TONYSVP SUPPLY CHAIN/COO SHARED SV	(i) (ii)	413,134 ------------- 0	318,925 ------------- 0	79,028 ------------- 0	51,400 ------------- 0	10,643 ------------- 0	873,130 ------------- 0	7,500 ------------- 0
14LANGFORD KATHRYNSVP NH/CLIN OPS	(i) (ii)	405,966 ------------- 0	234,045 ------------- 0	22,277 ------------- 0	124,096 ------------- 0	16,084 ------------- 0	802,468 ------------- 0	7,500 ------------- 0
15LINDSAY JEFFERYEVP & CHIEF OPERATING OFFICER	(i) (ii)	787,093 ------------- 0	481,548 ------------- 0	156,981 ------------- 0	59,400 ------------- 0	37,138 ------------- 0	1,522,160 ------------- 0	7,500 ------------- 0
16MORGAN WAYNESVP & CHIEF INVEST OFFICER	(i) (ii)	364,641 ------------- 0	187,168 ------------- 0	10,927 ------------- 0	118,237 ------------- 0	33,450 ------------- 0	714,423 ------------- 0	7,500 ------------- 0
17MYERS SCOTTSVP CORPORATE FINANCE	(i) (ii)	359,267 ------------- 0	181,976 ------------- 0	17,928 ------------- 0	117,021 ------------- 0	11,565 ------------- 0	687,757 ------------- 0	7,500 ------------- 0
18PATEFIELD MD ARTHURSVP & CHIEF MED INFO OFF	(i) (ii)	409,043 ------------- 0	253,110 ------------- 0	31,599 ------------- 0	65,400 ------------- 0	35,819 ------------- 0	794,971 ------------- 0	7,500 ------------- 0
19PHIPPS JOHN MDEVP & PRESIDENT NHMG	(i) (ii)	0 ------------- 517,596	0 ------------- 378,793	0 ------------- 25,651	0 ------------- 159,999	0 ------------- 35,382	0 ------------- 1,117,421	0 ------------- 7,500
20SEEHAUSEN ROBERTSVP BUSINESS DEV & SALES	(i) (ii)	423,222 ------------- 0	240,789 ------------- 0	84,346 ------------- 0	65,116 ------------- 0	32,224 ------------- 0	845,697 ------------- 0	7,498 ------------- 0
21SMITH-HILL JANETEVP & CHIEF HR OFFICER	(i) (ii)	420,648 ------------- 0	241,871 ------------- 0	24,625 ------------- 0	118,600 ------------- 0	30,642 ------------- 0	836,386 ------------- 0	7,500 ------------- 0
22VINCENT PAULASVP NH	(i) (ii)	118,606 ------------- 252,429	206,746 ------------- 0	34,803 ------------- 9,743	17,500 ------------- 39,624	3,538 ------------- 10,714	381,193 ------------- 312,510	0 ------------- 7,500
23WOOLLEN THOMAS MDSVP PHYSICIAN SERVICES	(i) (ii)	383,358 ------------- 0	194,500 ------------- 0	20,751 ------------- 0	121,650 ------------- 0	35,802 ------------- 0	756,061 ------------- 0	7,500 ------------- 0
24ZWENG THOMAS MDEVP & CHIEF MEDICAL OFFICER	(i) (ii)	540,299 ------------- 0	355,277 ------------- 0	31,615 ------------- 0	170,124 ------------- 0	41,134 ------------- 0	1,138,449 ------------- 0	7,500 ------------- 0
25GREGORY CHERE MDSVP WOMEN'S SERVICES	(i) (ii)	359,866 ------------- 0	180,717 ------------- 0	11,547 ------------- 0	111,045 ------------- 0	28,263 ------------- 0	691,438 ------------- 0	0 ------------- 0
26DUVALL DAVIDSVP MARKETING & COMMUNICATIONS	(i) (ii)	345,205 ------------- 0	168,036 ------------- 0	16,591 ------------- 0	115,680 ------------- 0	23,309 ------------- 0	668,821 ------------- 0	0 ------------- 0
27EASTERLING DONALDSVP NH CONSUMER OPERATIONS	(i) (ii)	360,556 ------------- 0	154,900 ------------- 0	29,311 ------------- 0	102,900 ------------- 0	22,825 ------------- 0	670,492 ------------- 0	0 ------------- 0
28GRIFFIN JONSVP FINANCIAL PLAN & ANALYSIS	(i) (ii)	350,669 ------------- 0	178,400 ------------- 0	16,135 ------------- 0	110,903 ------------- 0	33,126 ------------- 0	689,233 ------------- 0	0 ------------- 0
29PARK DAVIDSVP REAL ESTATE & CONSTRUCTION	(i) (ii)	309,078 ------------- 0	188,150 ------------- 0	42,140 ------------- 0	65,400 ------------- 0	24,812 ------------- 0	629,580 ------------- 0	7,500 ------------- 0
30VANCE AMYSVP POPULATION HEALTH MGMT	(i) (ii)	336,763 ------------- 0	192,314 ------------- 0	22,388 ------------- 0	108,724 ------------- 0	24,028 ------------- 0	684,217 ------------- 0	7,500 ------------- 0
31WILES PAULFORMER CEO & PRESIDENT NOVANT HEALTH	(i) (ii)	0 ------------- 0	0 ------------- 0	153,250 ------------- 0	0 ------------- 0	0 ------------- 0	153,250 ------------- 0	0 ------------- 0
32BEIER GREGORYFORMER EVP	(i) (ii)	0 ------------- 0	0 ------------- 0	20,086 ------------- 0	0 ------------- 0	0 ------------- 0	20,086 ------------- 0	132,025 ------------- 0
33BILLINGS DERRICK MARKFORMER PRESIDENT NH SHARED SERVICES	(i) (ii)	0 ------------- 0	246,139 ------------- 0	542,725 ------------- 0	0 ------------- 0	1,664 ------------- 0	790,528 ------------- 0	0 ------------- 0
34GARDELLA JOHN MDVP CLINICAL IMPROVEMENT	(i) (ii)	305,769 ------------- 0	182,074 ------------- 0	12,198 ------------- 0	54,730 ------------- 0	20,933 ------------- 0	575,704 ------------- 0	0 ------------- 0
35LINER SALLYEFORMER EVP & CHIEF CLINICAL OFFICER	(i) (ii)	271,727 ------------- 0	440,395 ------------- 0	21,687 ------------- 0	54,893 ------------- 0	10,689 ------------- 0	799,391 ------------- 0	7,500 ------------- 0
36MILLER MARKFORMER SVP OPERATIONAL FINANCE	(i) (ii)	26,685 ------------- 0	347,558 ------------- 0	450,780 ------------- 0	20,862 ------------- 0	30,385 ------------- 0	876,270 ------------- 0	7,500 ------------- 0
37WALLENHAUPT STEPHENFMR EVP & CMO	(i) (ii)	351,054 ------------- 0	182,353 ------------- 0	21,876 ------------- 0	57,900 ------------- 0	31,114 ------------- 0	644,297 ------------- 0	7,500 ------------- 0

Return Reference	Explanation
PART I, LINE 1A	PART I, LINE 1A: FRINGE OR EXPENSE EXPLANATION FIRST-CLASS OR CHARTER TRAVEL: FIRST-CLASS OR CHARTER TRAVEL IS NOT A COVERED TRAVEL EXPENSE FOR EXECUTIVES; THEY ARE LIMITED TO BUSINESS OR COACH CLASS FARES FOR COMMERCIAL FLIGHTS. HOWEVER, CHARTER TRAVEL IS AVAILABLE TO CERTAIN EXECUTIVES, BOARD MEMBERS, AND APPROVED BUSINESS PERSONNEL MEETING APPLICABLE POLICY CRITERIA. TRAVEL FOR COMPANIONS: COMPANIONS ARE ALLOWED ON CERTAIN CHARTER FLIGHTS PAID FOR BY THE ORGANIZATION. IN THAT CASE, THE VALUE OF THE COMPANION'S FLIGHT IS CALCULATED UNDER APPLICABLE TAX LAWS AND THAT AMOUNT IS INCLUDED IN THE EXECUTIVE'S TAXABLE INCOME AS PRESCRIBED BY THE APPLICABLE TAX LAWS. TAX INDEMNIFICATION AND GROSS-UP PAYMENTS: EXECUTIVES WHO USE FUNDS MADE AVAILABLE THROUGH THEIR DISCRETIONARY SPENDING ACCOUNT UNDER THE EXECUTIVE PERQUISITE PLAN (THE "PLAN") TO PAY PREMIUMS ON CASH VALUE LIFE INSURANCE POLICIES MAY RECEIVE ADDITIONAL COMPENSATION TO ADJUST FOR THE INCOME TAX LIABILITY ASSOCIATED WITH PAYING PREMIUMS FOR THIS INSURANCE. EXECUTIVES WHO RECEIVE TAXABLE RELOCATION INCOME MAY HAVE THE ADDITIONAL INCOME TAX OWED ON THE INCOME PAID BY THE ORGANIZATION. EXECUTIVES MAY RECEIVE AS SEVERANCE BENEFITS CASH PAYMENTS IN LIEU OF PREMIUMS PAID FOR COVERAGE OF CERTAIN BENEFITS THAT ENDED WITH THE EXECUTIVE'S TERMINATION. THE ORGANIZATION MAY PAY THE ADDITIONAL TAX OWED ON ACCOUNT OF THESE PAYMENTS. DISCRETIONARY SPENDING ACCOUNT: CERTAIN EXECUTIVES RECEIVE A DISCRETIONARY SPENDING ACCOUNT. THE DOLLAR AMOUNT IN THE ACCOUNT IS PRE-APPROVED BY THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE NOVANT HEALTH BOARD OF TRUSTEES. THE ACCOUNT CAN BE USED ONLY FOR AN APPROVED LIST OF EXPENDITURES. ALL OPTIONS OTHER THAN A DEFERRED, AT-RISK, COMPENSATION OPTION ARE CONSIDERED TAXABLE AND ARE INCLUDED IN THE EXECUTIVE'S TAXABLE INCOME AS PRESCRIBED BY THE APPLICABLE TAX LAWS. HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE: WE PROVIDE TEMPORARY HOUSING ALLOWANCES IN CERTAIN EXECUTIVE RECRUITMENT AND RELOCATION PACKAGES. IN THE CASE THAT SUCH EXPENSE IS NOT REIMBURSABLE UNDER THE ACCOUNTABLE PLAN RULES, THE VALUE IS CALCULATED UNDER APPLICABLE TAX LAWS AND THAT AMOUNT IS INCLUDED IN THE EXECUTIVE'S INCOME AS PRESCRIBED BY THE APPLICABLE TAX LAWS. HEALTH OR SOCIAL CLUB DUES OR INITIATION FEES: IN CASES WHERE CORPORATE MEMBERSHIPS ARE NOT AVAILABLE, A MEMBERSHIP MAY BE OBTAINED IN AN EXECUTIVE'S NAME WITH A "BUSINESS USE ONLY" RESTRICTION.
PART I, LINES 4A-C	PART I, LINES 4A-C: SEVERANCE, NONQUALIFIED, AND EQUITY-BASED PAYMENTS SEVERANCE NONQUALIFIED EQUITY-BASED ALUKO, AKINYELE 67,632 BEIER, GREGORY 124,831 BILLINGS, DERRICK 543,738 BRUNSTETTER, PETER 92,700 COOK, DAVID 65,663 CURETON, JESSE 118,821 DUVALL, DAVID 50,280 EASTERLING, DONALD 52,500 GARMON-BROWN, OPHELIA 54,075 GARRETT, DAVID 64,754 GREGORY, CHERE 52,500 GRIFFIN, JON 51,503 LANGFORD, KATHRYN 58,710 MILLER, MARK 370,800 MORGAN, WAYNE 53,310 MYERS, SCOTT 51,621 PHIPPS, JOHN 100,602 SMITH-HILL, JANET 61,200 VANCE, AMY 49,332 WILES, PAUL 69,791 130,000 WOOLLEN, THOMAS 56,250 ZWENG, THOMAS 105,000
PART III - OTHER ADDITIONAL INFORMATION	DESCRIPTIONS OF SUPPLEMENTAL EXECUTIVE BENEFITS INCLUDED IN PART VII AND SCHEDULE J: EXECUTIVE ANNUAL INCENTIVE PLAN: AS PART OF THE REPORTED COMPENSATION AMOUNTS, THE REPORTING ORGANIZATION PROVIDES ANNUAL INCENTIVE COMPENSATION TO CERTAIN KEY EXECUTIVES UNDER AN EXECUTIVE ANNUAL INCENTIVE PLAN. THE INCENTIVE PLAN IS DESIGNED TO OFFER OPPORTUNITIES FOR ADDITIONAL COMPENSATION, BUT ONLY TO THE EXTENT THAT ELIGIBLE EXECUTIVES HAVE PROVIDED EXTRAORDINARY SERVICES AND ACHIEVED EXTRAORDINARY RESULTS THAT MEET OR EXCEED PREDETERMINED GOALS IN THE AREAS OF QUALITY, PATIENT SATISFACTION, EMPLOYEE SATISFACTION AND FINANCIAL VITALITY. THESE GOALS ARE ESTABLISHED AND APPROVED BY INDEPENDENT AND DISINTERESTED MEMBERS OF THE NOVANT HEALTH BOARD OF TRUSTEES (WHO COMPRISE THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD). THESE GOALS ARE WEIGHTED EQUALLY. THE ADDITIONAL COMPENSATION CAN RANGE ANYWHERE FROM ZERO TO A MAXIMUM PERCENTAGE OF BASE SALARY THAT DIFFERS BY THE CLASS OF EXECUTIVE. IN ADDITION, THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD WHO OVERSEE THE INCENTIVE COMPENSATION PROGRAM APPLY TWO "CIRCUIT BREAKERS," WHICH ARE SUBSTANTIAL LEVELS OF ORGANIZATION-WIDE ACHIEVEMENT THAT MUST BE SATISFIED BEFORE ANY AWARDS ARE PAID TO ANY EXECUTIVE UNDER THE PROGRAM. THE INCENTIVE COMPENSATION AWARDS HAVE BEEN INCLUDED IN THE COMPENSATION AMOUNTS REPORTED IN PART VII AND IN COLUMN (B)(II) OF SCHEDULE J. THEY ARE REPORTED IN THE YEAR PAID. THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD REVIEW, APPROVE, AND OVERSEE ALL ASPECTS AND ALL ELEMENTS OF EXECUTIVE COMPENSATION AND BENEFITS, INCLUDING THE AMOUNTS AWARDED UNDER THIS ANNUAL INCENTIVE PLAN. LONG-TERM INCENTIVE PLAN: THE REPORTING ORGANIZATION OFFERS A LONG-TERM INCENTIVE PLAN (THE "PLAN") TO CERTAIN KEY EXECUTIVES. THE PLAN TIES A KEY EXECUTIVE'S COMPENSATION TO THE ORGANIZATION'S LONG-TERM STRATEGIC PERFORMANCE, PROVIDES A RETENTION INCENTIVE FOR KEY EXECUTIVES, AND ALLOWS THE ORGANIZATION TO COMPETE IN THE MARKETPLACE FOR TOP LEADERSHIP TALENT. THE PLAN OPERATES ON THREE-YEAR PERFORMANCE CYCLES THAT BEGIN EACH YEAR. LONG-TERM STRATEGIC GOALS (IN THE PRINCIPAL AREAS OF QUALITY OF PATIENT CARE AND LONG-TERM FINANCIAL STRENGTH) ARE ESTABLISHED AND APPROVED FOR EACH CYCLE, IN ADVANCE, BY INDEPENDENT AND DISINTERESTED MEMBERS OF THE NOVANT HEALTH BOARD OF TRUSTEES (WHO COMPRISE THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD). NOVANT HEALTH'S INTERNAL AUDIT DEPARTMENT REVIEWS THE METHODOLOGY AND PROCESS USED TO DETERMINE ACHIEVEMENT OF THE QUALITY METRICS. IN ADDITION, THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD WHO OVERSEE THE INCENTIVE COMPENSATION PROGRAM APPLY TWO "CIRCUIT BREAKERS," RELATING TO COMMUNITY HEALTH NEEDS ASSESSMENTS AND IMPLEMENTATION PLANS, AND FINANCIAL PERFORMANCE; AWARDS ARE PAYABLE FOR A PARTICULAR THREE-YEAR PERFORMANCE CYCLE ONLY IF THE CIRCUIT BREAKERS ARE MET FOR THE RESPECTIVE THREE-YEAR PERFORMANCE PERIOD. IF AN AWARD IS EARNED AT THE END OF A PERFORMANCE CYCLE, THEN THE INCENTIVE AWARD IS PAID OUT AND IS INCLUDED IN THE COMPENSATION AMOUNTS REPORTED IN PART VII AND IN COLUMN (B)(II) OF SCHEDULE J. THEY ARE REPORTED IN THE YEAR PAID. THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD REVIEWS, APPROVES, AND OVERSEES ALL ASPECTS AND ALL ELEMENTS OF EXECUTIVE COMPENSATION AND BENEFITS, INCLUDING THE AMOUNTS AWARDED UNDER THE PLAN. PART I, LINE 4A - SEVERANCE PLAN: ELIGIBLE EXECUTIVES MAY RECEIVE SEVERANCE PAY THAT IS BASED ON ANNUAL COMPENSATION FOR A SPECIFIED PERIOD OF TIME. THE SEVERANCE PAY WOULD BE PAID ONLY IN THE EVENT OF CERTAIN TYPES OF EMPLOYMENT TERMINATION, AND IS FURTHER CONTINGENT ON THE SATISFACTION OF OTHER CONDITIONS SUCH AS COMPLIANCE WITH A NON-COMPETITION COVENANT. ANY CURRENT YEAR PAYMENTS HAVE BEEN INCLUDED IN THE COMPENSATION AMOUNTS REPORTED IN PART VII AND IN COLUMN (B)(III) OF SCHEDULE J. THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE BOARD REVIEWS, APPROVES, AND OVERSEES ALL ASPECTS AND ALL ELEMENTS OF EXECUTIVE COMPENSATION AND BENEFITS, INCLUDING THE AMOUNTS AWARDED UNDER THIS SEVERANCE PLAN. PART I, LINE 4B - SUPPLEMENTAL NONQUALIFIED RETIREMENT PLANS: THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ("SERP") IS INTENDED TO SUPPORT RETENTION OF KEY EXECUTIVES, AND TO OFFER COMPETITIVE TOTAL COMPENSATION. ELIGIBLE EXECUTIVES WILL BE NOMINATED BY THE CEO AND APPROVED BY THE COMMITTEE TO PARTICIPATE. GENERALLY, ANNUAL CONTRIBUTIONS TO THE PLAN OR PAYMENTS TO PARTICIPANTS WILL BE BASED ON A PERCENTAGE OF THE PARTICIPANT'S BASE SALARY AS OF JANUARY 1ST OF THE PREVIOUS PLAN YEAR AND ARE REPORTED IN COLUMN (C) OF SCHEDULE J. PRIOR TO MAKING THE CONTRIBUTIONS OR PAYMENTS, THE COMMITTEE WILL APPROVE THE AMOUNTS AS TO REASONABLENESS, WHEN COMBINED WITH ALL OTHER ANNUAL COMPENSATION. A 3 YEAR CLASS-YEAR VESTING PERIOD WILL APPLY UP TO AGE 62, WHEN ALL MONEY WOULD BE VESTED AND PAID OUT TO THE PARTICIPANT. OTHERWISE, VESTING WILL OCCUR ON JANUARY 1ST OF EACH YEAR FOR THE APPROPRIATE CLASS-YEAR VESTING PERIOD. THE COMMITTEE REVIEWS, APPROVES, AND OVERSEES ALL ASPECTS AND ALL ELEMENTS OF EXECUTIVE COMPENSATION AND BENEFITS. SHARE OPTION PLAN: IN 2002, IN FULL COMPLIANCE WITH IRS RULES IN PLACE AT THAT TIME, NOVANT HEALTH, INC. ALLOWED CERTAIN SENIOR EXECUTIVES TO WAIVE THEIR RIGHTS TO EVENTUALLY RECEIVE BENEFITS UNDER THE ORGANIZATION'S SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP) AND INSTEAD PARTICIPATE IN A SHARE OPTION PLAN UNDER WHICH THEY COULD OBTAIN OPTION GRANTS OF EQUIVALENT VALUE TO PURCHASE MUTUAL FUND SHARES. THE IRS RULES SUBSEQUENTLY CHANGED, AND ACCORDINGLY NO ADDITIONAL OPTIONS WERE GRANTED AFTER MAY 8, 2002. MR. WILES RETIRED IN 2011 AFTER 40 YEARS OF SERVICE TO THE ORGANIZATION. IN 2012, MR. WILES EXERCISED THE MAJORITY OF HIS OPTIONS UNDER THE SHARE OPTION PLAN, AS REPORTED ON NOVANT HEALTH'S 2012 FORM 990. IN 2015, MR. WILES EXERCISED ADDITIONAL OPTIONS UNDER THE PLAN AND RECEIVED $130,000 IN REPORTABLE COMPENSATION INCLUDED ON A FORM W-2 ISSUED TO MR. WILES. THIS TOTAL AMOUNT IS INCLUDED IN THE COMPENSATION AMOUNTS REPORTED IN PART VII OF THE FORM 990, AND IN COLUMN (B)(III) OF PART II OF SCHEDULE J OF THE FORM 990. RETIREMENT SECURITY AGREEMENT: RETIREMENT SECURITY AGREEMENTS ("RSAS") ENTERED INTO BY A PREDECESSOR ENTITY IN 1994 WERE ASSUMED BY NOVANT HEALTH, INC. AND SUBSEQUENTLY APPROVED BY THE COMPENSATION & LEADERSHIP COMMITTEE FOR TWO PARTICIPANTS, WHICH PROVIDED FOR SUPPLEMENTAL RETIREMENT BENEFITS COMMENCING AT AGE 60. ANY CURRENT YEAR PAYMENTS OF RSA BENEFITS TO THESE PARTICIPANTS ARE INCLUDED IN THE COMPENSATION AMOUNTS REPORTED IN PART VII OF THE FORM 990 AND IN COLUMN (B)(III) OF PART II OF SCHEDULE J OF THE FORM 990.

Software ID:
Software Version: